2021
DOI: 10.1159/000518737
|View full text |Cite
|
Sign up to set email alerts
|

Chronic Eosinophilic Leukaemia Associated with <b><i>JAK2</i></b> Exon 13 Insertion/Deletion Mutations

Abstract: Chronic eosinophilic leukaemia, not otherwise specified (CEL, NOS), is a diagnosis of exclusion made in cases in which there is clonal eosinophilia but an absence of genetic aberrations that define other disease subtypes. There is a need for further characterization of these cases in order to inform risk stratification and management. The importance of <i>JAK2</i> mutations in myeloproliferative neoplasms (MPN) as a whole is well established, although their role specifically in eosinophilic disorde… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(1 citation statement)
references
References 18 publications
0
0
0
Order By: Relevance
“…Somatic JAK2 ex13InDel mutations occurring in isolation have been described in CEL, but the absence of additional molecular abnormalities may be more reflective of the limits of clinical NGS panels. 18 As outlined in this report and in prior studies, 3 dual disease phenotypes that meet histopathologic criteria for both CEL and either MPN or MDS/MPN appear to carry an exceptionally high risk of thrombosis that is in large part driven by clonal hypereosinophilia. 3 These rare cases appear to be highly associated with non-V617F somatic JAK2 mutations such as JAK2 ex13InDel and JAK2 R683S.…”
Section: Discussionsupporting
confidence: 53%
“…Somatic JAK2 ex13InDel mutations occurring in isolation have been described in CEL, but the absence of additional molecular abnormalities may be more reflective of the limits of clinical NGS panels. 18 As outlined in this report and in prior studies, 3 dual disease phenotypes that meet histopathologic criteria for both CEL and either MPN or MDS/MPN appear to carry an exceptionally high risk of thrombosis that is in large part driven by clonal hypereosinophilia. 3 These rare cases appear to be highly associated with non-V617F somatic JAK2 mutations such as JAK2 ex13InDel and JAK2 R683S.…”
Section: Discussionsupporting
confidence: 53%